Skip to main content

Pliant Therapeutics, Inc.

PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001746473

No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Pliant Therapeutics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of PLRX: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders91186−4
Shares49.7M21248.1M−1.58M (−3.2%)
Value$62.5M$267$54.8M−$7.65M (−12.2%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (9)

Institutions that held Pliant Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to PLRX in Q2 2026
InstitutionSharesValue% of portfolio
Lynx1 Capital Management LP1,798,070$2.05M0.24%
Ikarian Capital, LLC1,000,000$1.14M0.19%
Boothbay Fund Management, LLC303,000$345.4K0.01%
Marquette Asset Management, LLC174,500$198.9K0.03%
Headlands Technologies LLC33,688$38.4K0.00%
Spark Investment Management LLC22,600$25.8K0.05%
GWM Advisors LLC15,000$17.1K0.00%
IFG Advisory, LLC4$50.00%
Global Retirement Partners, LLC4$50.00%

Sold out (13)

Institutions that held Pliant Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of PLRX in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Blue Owl Capital Holdings LP2,969,199$3.74M
Centiva Capital, LP432,525$545.0K
Bank of America Corp352,708$444.4K
Hennion & Walsh Asset Management, Inc.106,705$134.4K
Bronte Capital Management Pty Ltd.18,613$23.5K
SG Americas Securities, LLC12,604$16.0K
HRT Financial LP11,196$14.0K
JustInvest LLC10,029$12.6K
Tower Research Capital LLC (TRC)3,315$4.18K
Rhumbline Advisers2,379$3.00K
Owl Creek Wealth Partners LLC2,300$2.90K
MAI Capital Management400$504
Northwestern Mutual Wealth Management Co100$126

Not filed for Q2 2026 yet (1)

Institutions that held Pliant Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PLRX in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
CWM, LLC212$267